Delivery Order SPE2DB24D2101-SPE2DB25FKPEK
- Not listed
- The Defense Logistics Agency awarded a $54,357.69 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for Enbrel 50 mg/mL SureClick auto-injector pens. This non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be performed at AmerisourceBergen's corporate headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded a $39,049.72 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This competitively awarded, firm fixed-price contract serves as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $52,670.24 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with a completion date of September 8, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $7,091.69 firm fixed price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors on September 2, 2025, with an ultimate completion date of September 3, 2025. This non-set-aside delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply contract with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $67,384.37 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. The contract, which is firm fixed price with no set-aside designation, was competitively awarded on August 5, 2025, with an ultimate completion date of August 6, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance. This delivery order represents a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for $43,813.23 to supply Enbrel 50 mg/mL SureClick auto-injectors. This non-competitive, firm fixed price delivery order is set to conclude on June 4, 2025, and will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of ENBREL 50 mg/mL SureClick auto-injectors, valued at $75,184.20. This firm fixed-price delivery order, with an ultimate completion date of August 8, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively procured with no set-aside designation...
- The Defense Logistics Agency awarded a $13,844.92 delivery order to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This non-set-aside, competitively awarded contract utilized firm fixed pricing and was completed on July 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of the company's established role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency awarded a $39,057.22 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors, with an ultimate completion date of July 7, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $76,320.35 to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, which carries an ultimate completion date of September 19, 2025, was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKPEKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at approximately $37,038 to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injector pens. This is a firm fixed price, competitively awarded contract with no set-aside designation, with ultimate completion scheduled for September 5, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its comprehensive DLA Troop Support Medical contract vehicle. The IDC enables the company to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs globally. This specific delivery order for Enbrel, a rheumatoid arthritis treatment medication, exemplifies the company's role in fulfilling specialized pharmaceutical requirements for federal medical supply chains across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.0k | 9/4/25 |